Administration of recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation in children with acute myelogenous leukemia: A note of caution

Bone Marrow Transplantation

Volumn 18, Issue 1, 1996, Pages 87-91

  Calderwood, S ^a   Doyle, J J ^a   Hitzler, J K ^a   Saunders, E F ^a   Freedman, M H ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

ABMT; AML; Outcome; Pediatric; RhGM CSF

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HUMAN; LENGTH OF STAY; MALE; NEUTROPHIL; PEDIATRICS; PRIORITY JOURNAL; RECURRENCE RISK; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

ACUTE DISEASE; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INFANT; LEUKEMIA, MYELOID; LIFE TABLES; MALE; NEUTROPENIA; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 0029739219     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Nesbit ME Jr, Buckley JD, Feig SA et al. Chemotherapy for induction of remission of childhood acute myeloid leukemia followed by marrow transplantation or multiagent chemotherapy: a report from the Childrens Cancer Group. J Clin Oncol 1994; 12: 127-135.
2. Gale RP, Horowitz MM, Rees JKH et al. Chemotherapy versus transplants for acute myelogenous leukemia in second remission. Leukemia 1996; 10: 13-19.
3. Santos GW. Bone marrow transplantation in hematological malignancies. Cancer 1990; 65: 786-791.
4. Meloni G, De Fabritiis P, Petti MC, Mandelli F. BAVC regimen and autologous bone marrow transplantation in patients with acute myelogenous leukemia in second remission. Blood 1990; 75: 2282-2285.
5. Feig SA, Nesbit ME, Buckley J et al. Bone marrow transplantation for acute non-lymphocytic leukemia: a report from the Childrens Cancer Study Group of 67 children transplanted in first remission. Bone Marrow Transplant 1987; 2: 365-374.
6. Michel G, Gluckman E, Balise D et al. Improvement in outcome for children receiving allogeneic bone marrow transplantation in first remission of acute myeloid leukemia: a report from the Groupe d'Etude des Greffes de Moelle Osseuse. J Clin Oncol 1992; 10: 1865-1869.
7. Sanders JE, Thomas ED, Buckner CD et al. Marrow transplantation for children in first remission of acute nonlymphoblastic leukemia: an update. Blood 1985; 66: 460-462.
8. Dahl GV, Kalwinsky DK, Mirro J Jr et al. Allogeneic bone marrow transplantation in a program of intensive sequential chemotherapy for children and young adults with acute non-lymphocytic leukemia in first remission. J Clin Oncol 1990; 8: 295-303.
9. Gorin NC. Autologous bone marrow transplantation for acute leukemia. The status in 1994. Autologous Blood and Marrow Transplantation: Proc Seventh Int Symp, Arlington, Texas. 17-20 August 1994; 27-32
10. Singer JW, Nemunaitis J. Use of recombinant growth factors in bone marrow transplantation. In: Forman SJ, Blume KG, Donnall Thomas E (eds). Bone Marrow Transplantation. Blackwell Scientific: Boston, 1994, pp 309-326.
11. Mazanet R, Griffin JD. Hematopoietic growth factors. In: Armitage JO, Antman KH (eds). High Dose Cancer Therapy. Williams and Wilkins: Baltimore, 1992, 289-313.
12. Nomoto N, Shibata A. Capability of various cytokines to induce quiescent myeloid leukemia cells to the proliferative stage. Leuk Lymphoma 1992; 7: 143-150.
13. Estey EH. Use of colony-stimulating factors in the treatment of acute myeloid leukemia. Blood 1994; 83: 2015-2019 (editorial).
14. Van Der Lely N, De Witte T, Wessels J et al. In vitro response of blasts to IL-3, GM-CSF, and G-CSF is different for individual AML patients: factors that stimulate leukemic clonogenic cells also enhance Ara-C cytotoxicity. Ann Hematol 1994; 68: 225-232.
15. Estey E, Thall PF, Kantarjian H et al. Treatment of newly diagnosed acute myelogenous leukemia with granulocyte-macrophage colony-stimulating factor (GM-CSF) before and during continuous-infusion high-dose ara-C + daunorubicin: comparison to patients treated without GM-CSF. Blood 1992; 79: 2246-2255.
16. Rowe JM, Andersen JW, Mazza JJ et al. A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (>55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490). Blood 1995; 86: 457-462.
17. Nemunaitis J, Rosenfeld CS, Ash R et al. Phase III randomized, double-blind placeo-controlled trial of rhGM-CSF following allogeneic bone marrow transplantation. Bone Marrow Transplant 1995; 15: 949-954.
18. Gupta P, Tiley C, Powles R et al. No increase in relapse in patients with myeloid leukaemias receiving rhGM-CSF after allogeneic bone marrow transplantation. Bone Marrow Transplant 1992; 9: 491-493.
19. Thomas ED, Storb R. Technique for human marrow grafting. Blood 1970; 36: 507-515.
20. Kaplan EL, Meier P. Nonparametric estimations from incomplete observations. J Am Stat Assoc 1958; 54: 457-481.
21. Ball ED, Mills LE, Gibbons GC III et al. Autologous bone marrow transplantation for acute myeloid leukemia using monoclonal antibody-purged bone marrow. Blood 1990; 75: 1199-1206.
22. Yeager AM, Kaizer H, Santos GW et al. Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide. New Engl J Med 1986; 315: 141-147.
23. Linch DC, Burnett AK. Clinical study of ABMT in acute myeloid leukaemia. Clin Haematol 1986; 15: 167-186.